Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urologic Diseases 1Shock 1Rheumatic Diseases 1Renal Insufficiency 1Nervous System Diseases 1Kidney Diseases 1Infections 1Hematologic Diseases 1Heart Failure 1Gastrointestinal Diseases 1Critical Illness 1Cardiovascular Diseases 1Asthma 1Arrhythmias, Cardiac 1

Interventions

Oxaliplatin 3Magnetic Resonance Spectroscopy 3Exercise Test 2Cyclophosphamide 2Capecitabine 2trifluridine tipiracil drug combination 1penpulimab 1pembrolizumab 1lutetium Lu 177 dotatate 1huachansu 1guadecitabine 1copper dotatate CU-64 1XELOX 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Restraint, Physical 1Physical Examination 1Oviposition 1Observation 1Lutetium-177 1Lutetium 1Irinotecan 1Indocyanine Green 1Hyperthermic Intraperitoneal Chemotherapy 1Health Information Exchange 1Gemcitabine 1Gastroscopy 1Fluorouracil 1Fluorescein 1Endoscopy, Digestive System 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Diseases × Health Information Exchange × Clear all
NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

Brigham and Women's Hospital

Phase NA Enrolling by invitation
1,006 enrolled
GastrointestinalGenitourinary

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡